The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Burns Treatment Market Research Report 2025

Global Burns Treatment Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1885430

No of Pages : 92

Synopsis
The global Burns Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Burns Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Burns Treatment.
Report Scope
The Burns Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Burns Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Burns Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Adocia
AlgiPharma AS
Amarantus Bioscience Holdings, Inc.
American Gene Technologies International Inc.
Biogenomics Limited
CytoTools AG
Destiny Pharma Limited
Lakewood-Amedex Inc
Madam Therapeutics B.V.
MediWound Ltd.
Mitochon Pharmaceuticals, Inc.
Phosphagenics Limited
Se-cure Pharmaceuticals Ltd.
Sinclair Pharma Plc
Stratatech Corporation
Tissue Therapies Limited
USV Pvt Ltd
Segment by Type
ENERGIF-711
AG-110
NJ-01SS
P-148
Others
Segment by Application
In-patient
Out-patient
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Burns Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Burns Treatment Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 ENERGIF-711
1.2.3 AG-110
1.2.4 NJ-01SS
1.2.5 P-148
1.2.6 Others
1.3 Market by Application
1.3.1 Global Burns Treatment Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 In-patient
1.3.3 Out-patient
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Burns Treatment Market Perspective (2019-2030)
2.2 Burns Treatment Growth Trends by Region
2.2.1 Global Burns Treatment Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Burns Treatment Historic Market Size by Region (2019-2024)
2.2.3 Burns Treatment Forecasted Market Size by Region (2025-2030)
2.3 Burns Treatment Market Dynamics
2.3.1 Burns Treatment Industry Trends
2.3.2 Burns Treatment Market Drivers
2.3.3 Burns Treatment Market Challenges
2.3.4 Burns Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Burns Treatment Players by Revenue
3.1.1 Global Top Burns Treatment Players by Revenue (2019-2024)
3.1.2 Global Burns Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Burns Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Burns Treatment Revenue
3.4 Global Burns Treatment Market Concentration Ratio
3.4.1 Global Burns Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Burns Treatment Revenue in 2023
3.5 Burns Treatment Key Players Head office and Area Served
3.6 Key Players Burns Treatment Product Solution and Service
3.7 Date of Enter into Burns Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Burns Treatment Breakdown Data by Type
4.1 Global Burns Treatment Historic Market Size by Type (2019-2024)
4.2 Global Burns Treatment Forecasted Market Size by Type (2025-2030)
5 Burns Treatment Breakdown Data by Application
5.1 Global Burns Treatment Historic Market Size by Application (2019-2024)
5.2 Global Burns Treatment Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Burns Treatment Market Size (2019-2030)
6.2 North America Burns Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Burns Treatment Market Size by Country (2019-2024)
6.4 North America Burns Treatment Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Burns Treatment Market Size (2019-2030)
7.2 Europe Burns Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Burns Treatment Market Size by Country (2019-2024)
7.4 Europe Burns Treatment Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Burns Treatment Market Size (2019-2030)
8.2 Asia-Pacific Burns Treatment Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Burns Treatment Market Size by Region (2019-2024)
8.4 Asia-Pacific Burns Treatment Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Burns Treatment Market Size (2019-2030)
9.2 Latin America Burns Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Burns Treatment Market Size by Country (2019-2024)
9.4 Latin America Burns Treatment Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Burns Treatment Market Size (2019-2030)
10.2 Middle East & Africa Burns Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Burns Treatment Market Size by Country (2019-2024)
10.4 Middle East & Africa Burns Treatment Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Adocia
11.1.1 Adocia Company Detail
11.1.2 Adocia Business Overview
11.1.3 Adocia Burns Treatment Introduction
11.1.4 Adocia Revenue in Burns Treatment Business (2019-2024)
11.1.5 Adocia Recent Development
11.2 AlgiPharma AS
11.2.1 AlgiPharma AS Company Detail
11.2.2 AlgiPharma AS Business Overview
11.2.3 AlgiPharma AS Burns Treatment Introduction
11.2.4 AlgiPharma AS Revenue in Burns Treatment Business (2019-2024)
11.2.5 AlgiPharma AS Recent Development
11.3 Amarantus Bioscience Holdings, Inc.
11.3.1 Amarantus Bioscience Holdings, Inc. Company Detail
11.3.2 Amarantus Bioscience Holdings, Inc. Business Overview
11.3.3 Amarantus Bioscience Holdings, Inc. Burns Treatment Introduction
11.3.4 Amarantus Bioscience Holdings, Inc. Revenue in Burns Treatment Business (2019-2024)
11.3.5 Amarantus Bioscience Holdings, Inc. Recent Development
11.4 American Gene Technologies International Inc.
11.4.1 American Gene Technologies International Inc. Company Detail
11.4.2 American Gene Technologies International Inc. Business Overview
11.4.3 American Gene Technologies International Inc. Burns Treatment Introduction
11.4.4 American Gene Technologies International Inc. Revenue in Burns Treatment Business (2019-2024)
11.4.5 American Gene Technologies International Inc. Recent Development
11.5 Biogenomics Limited
11.5.1 Biogenomics Limited Company Detail
11.5.2 Biogenomics Limited Business Overview
11.5.3 Biogenomics Limited Burns Treatment Introduction
11.5.4 Biogenomics Limited Revenue in Burns Treatment Business (2019-2024)
11.5.5 Biogenomics Limited Recent Development
11.6 CytoTools AG
11.6.1 CytoTools AG Company Detail
11.6.2 CytoTools AG Business Overview
11.6.3 CytoTools AG Burns Treatment Introduction
11.6.4 CytoTools AG Revenue in Burns Treatment Business (2019-2024)
11.6.5 CytoTools AG Recent Development
11.7 Destiny Pharma Limited
11.7.1 Destiny Pharma Limited Company Detail
11.7.2 Destiny Pharma Limited Business Overview
11.7.3 Destiny Pharma Limited Burns Treatment Introduction
11.7.4 Destiny Pharma Limited Revenue in Burns Treatment Business (2019-2024)
11.7.5 Destiny Pharma Limited Recent Development
11.8 Lakewood-Amedex Inc
11.8.1 Lakewood-Amedex Inc Company Detail
11.8.2 Lakewood-Amedex Inc Business Overview
11.8.3 Lakewood-Amedex Inc Burns Treatment Introduction
11.8.4 Lakewood-Amedex Inc Revenue in Burns Treatment Business (2019-2024)
11.8.5 Lakewood-Amedex Inc Recent Development
11.9 Madam Therapeutics B.V.
11.9.1 Madam Therapeutics B.V. Company Detail
11.9.2 Madam Therapeutics B.V. Business Overview
11.9.3 Madam Therapeutics B.V. Burns Treatment Introduction
11.9.4 Madam Therapeutics B.V. Revenue in Burns Treatment Business (2019-2024)
11.9.5 Madam Therapeutics B.V. Recent Development
11.10 MediWound Ltd.
11.10.1 MediWound Ltd. Company Detail
11.10.2 MediWound Ltd. Business Overview
11.10.3 MediWound Ltd. Burns Treatment Introduction
11.10.4 MediWound Ltd. Revenue in Burns Treatment Business (2019-2024)
11.10.5 MediWound Ltd. Recent Development
11.11 Mitochon Pharmaceuticals, Inc.
11.11.1 Mitochon Pharmaceuticals, Inc. Company Detail
11.11.2 Mitochon Pharmaceuticals, Inc. Business Overview
11.11.3 Mitochon Pharmaceuticals, Inc. Burns Treatment Introduction
11.11.4 Mitochon Pharmaceuticals, Inc. Revenue in Burns Treatment Business (2019-2024)
11.11.5 Mitochon Pharmaceuticals, Inc. Recent Development
11.12 Phosphagenics Limited
11.12.1 Phosphagenics Limited Company Detail
11.12.2 Phosphagenics Limited Business Overview
11.12.3 Phosphagenics Limited Burns Treatment Introduction
11.12.4 Phosphagenics Limited Revenue in Burns Treatment Business (2019-2024)
11.12.5 Phosphagenics Limited Recent Development
11.13 Se-cure Pharmaceuticals Ltd.
11.13.1 Se-cure Pharmaceuticals Ltd. Company Detail
11.13.2 Se-cure Pharmaceuticals Ltd. Business Overview
11.13.3 Se-cure Pharmaceuticals Ltd. Burns Treatment Introduction
11.13.4 Se-cure Pharmaceuticals Ltd. Revenue in Burns Treatment Business (2019-2024)
11.13.5 Se-cure Pharmaceuticals Ltd. Recent Development
11.14 Sinclair Pharma Plc
11.14.1 Sinclair Pharma Plc Company Detail
11.14.2 Sinclair Pharma Plc Business Overview
11.14.3 Sinclair Pharma Plc Burns Treatment Introduction
11.14.4 Sinclair Pharma Plc Revenue in Burns Treatment Business (2019-2024)
11.14.5 Sinclair Pharma Plc Recent Development
11.15 Stratatech Corporation
11.15.1 Stratatech Corporation Company Detail
11.15.2 Stratatech Corporation Business Overview
11.15.3 Stratatech Corporation Burns Treatment Introduction
11.15.4 Stratatech Corporation Revenue in Burns Treatment Business (2019-2024)
11.15.5 Stratatech Corporation Recent Development
11.16 Tissue Therapies Limited
11.16.1 Tissue Therapies Limited Company Detail
11.16.2 Tissue Therapies Limited Business Overview
11.16.3 Tissue Therapies Limited Burns Treatment Introduction
11.16.4 Tissue Therapies Limited Revenue in Burns Treatment Business (2019-2024)
11.16.5 Tissue Therapies Limited Recent Development
11.17 USV Pvt Ltd
11.17.1 USV Pvt Ltd Company Detail
11.17.2 USV Pvt Ltd Business Overview
11.17.3 USV Pvt Ltd Burns Treatment Introduction
11.17.4 USV Pvt Ltd Revenue in Burns Treatment Business (2019-2024)
11.17.5 USV Pvt Ltd Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’